Core Insights - The company, Ruimait, closed at 88.87 yuan on August 5, with a 1.55% increase, resulting in a rolling PE ratio of 44.89 times and a total market value of 7.963 billion yuan [1] - In the medical device industry, the average PE ratio is 54.24 times, with a median of 37.92 times, placing Ruimait at the 83rd position in the industry ranking [1] - The company experienced a net inflow of 6.937 million yuan in principal funds on August 5, although it has seen a total outflow of 28.488 million yuan over the past five days [1] Company Overview - Ruimait specializes in manufacturing medical devices and consumables in the field of respiratory health, with key products including various types of sleep breathing machines and monitoring devices [1] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, along with 202 international patents [1] Financial Performance - In the first quarter of 2025, the company reported an operating income of 265 million yuan, reflecting a year-on-year increase of 38.11%, and a net profit of 71.9314 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] - The company's PE (TTM) is 44.89, while the industry average is 54.24, and the industry median is 37.92 [2]
瑞迈特收盘上涨1.55%，滚动市盈率44.89倍，总市值79.63亿元